Randall Kaye
CIK 1350416 · Executive Vice President & CMO · last filed 2024-12-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.35M
Companies
3
Total Filings
46
Lifetime Open-Market Net
-$2.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Executive Vice President & CMO | 0 | $59.98 | $0 | -$2.09M | 9 | 2024-12-02 |
| AXSM | Chief Medical Officer | 11,044 | $212.74 | $2.35M | $9.0K | 2 | 2015-12-24 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Sr. VP, Chief Medical Officer | 71,940 | — | — | -$745.7K | 33 | 2011-09-13 |
Recent Filings · Page 4 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-12-15 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Tax (F) | −1,350 | -$2.5K | EDGAR |
| 2009-11-30 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-09-15 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Mixed | −1,349 | -$2.8K | EDGAR |
| 2009-07-17 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Tax (F) | −23,425 | -$49.9K | EDGAR |
| 2009-06-15 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Tax (F) | −1,217 | -$1.6K | EDGAR |
| 2009-03-17 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Tax (F) | −1,440 | -$648 | EDGAR |
| 2009-02-25 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Buy (P) | +10,000 | $4.3K | EDGAR |
| 2008-12-18 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-09-17 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Tax (F) | −1,217 | -$1.0K | EDGAR |
| 2008-06-16 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Tax (F) | −1,217 | -$1.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.